# GHK-Cu: Research Overview — Peptide Batteries > A data-forward literature summary of GHK-Cu, the copper-binding tripeptide studied for collagen synthesis, gene expression, and hair growth. Mechanism, trial numbers, and cited safety cautions. A three-amino-acid, copper-binding signal molecule best documented in skin and hair — and this site's honest edge case for a cellular-energy frame. ## The short version GHK-Cu is a tiny, naturally occurring molecule — three amino acids (glycine, histidine, lysine) holding onto one copper atom. The body makes it, and its blood level drops steadily with age: from around 200 nanograms per milliliter at age 20 down to about 80 by age 60 [4]. It's best known as a skincare ingredient, studied for boosting collagen (the protein that keeps skin firm) and for slowing hair loss. In lab studies it also flips the activity of a startlingly large share of human genes — a claim few other peptides on this site can match [2]. This page reports what the research says about mechanism, gene expression, and skin/hair trial results, all cited by number. It is a topical cosmetic ingredient with a long safety record; it is not sold or recommended here for injectable or internal use. ## What it is GHK-Cu is the linear tripeptide Gly-His-Lys, chelated one-to-one with a Cu(II) ion through the histidine imidazole nitrogen, the glycine amino nitrogen, and a deprotonated amide nitrogen — leaving the lysine side chain free to interact with other molecules. The complex carries the molecular formula C14H23CuN6O4+. The GHK sequence is not synthetic in origin: it occurs naturally within the alpha-2(I) chain of type I collagen and within the extracellular matrix protein SPARC/osteonectin, which is presumably related to why plasma levels are highest in young adulthood and fall with age [4]. Structurally, GHK-Cu is about as simple as a bioactive peptide gets — three residues, one metal ion — but its downstream signaling is anything but simple. ## How it works GHK-Cu functions as both a copper delivery vehicle and a signaling molecule in its own right. At picomolar-to-nanomolar concentrations, it directly stimulates dermal fibroblasts to synthesize collagen, elastin, glycosaminoglycans, and the proteoglycan decorin, while rebalancing the enzymes that break matrix down (matrix metalloproteinases) against the proteins that inhibit them (TIMPs) [4]. The copper ion does mechanistic work of its own: it enables lysyl oxidase, the enzyme that cross-links collagen and elastin fibers, and it carries superoxide-dismutase-like antioxidant activity. The gene-expression side is the most striking part of the mechanism. Connectivity Map analysis found GHK alters expression of roughly 31.2% of human genes at a 50%-or-greater change threshold — 59% of the affected genes up, 41% down — with especially strong activation of the ubiquitin-proteasome system (41 genes up, 1 down) alongside DNA-repair and antioxidant gene sets, and suppression of NF-kB-driven inflammatory signaling [2]. Its documented mechanistic targets span dermal fibroblasts, keratinocytes, hair-follicle dermal papilla cells, vascular endothelial cells, lung fibroblasts, intestinal epithelium, and neurons — a broad footprint for a three-residue peptide. ## What the research shows The freshest anchor is a 2025 review confirming GHK-Cu's central formulation problem: poor stratum-corneum permeability (clogP -2.24). The same review reports procollagen synthesis increased in 70% of GHK-Cu-treated subjects, versus 50% for vitamin C and 40% for retinoic acid, and evaluates delivery-enhancement strategies including palmitoylation (Pal-GHK, clogP 1.14) and microneedle pretreatment, which drove roughly 134 nanomoles of GHK through intact skin where none permeated otherwise [1]. A 2018 gene-expression analysis is the source of the 31.2%-of-genes figure described above [2]. On the clinical-trial side, a 6-month trial of 45 men with androgenetic alopecia (Norwood-Hamilton stages II-V) tested a complex of 5-aminolevulinic acid and GHK peptide and found hair count increased by 52.6 at the 100 mg/mL concentration and 71.5 at 50 mg/mL, versus 9.6 with placebo (p<0.05), with no adverse events reported in any group [3] — the strongest controlled human efficacy signal for a GHK-containing topical, though it studied a combination product rather than pure GHK-Cu. A canonical 2015 review documents the same 70%-versus-50%-versus-40% collagen-synthesis comparison and the age-related plasma decline from roughly 200 to 80 ng/mL [4]. And a human skin-penetration study measured copper's transdermal permeability coefficient directly: 2.43 ± 0.51 × 10⁻⁴ cm/h, with 136.2 ± 17.5 µg/cm² of copper permeating over 48 hours and 97 ± 6.6 µg/cm² retained as a dermal depot [5]. ## Reported effects, cautions & safety People in skincare communities describe a fairly consistent pattern with topical copper-peptide (GHK-Cu) products — anecdotal, not clinical evidence, and never tied to a specific dose. The most common report is firmer, tighter-feeling skin that builds over several weeks of twice-daily use, followed by softer-looking fine lines after six to twelve weeks and, often within the first week or two, better hydration and a plumper feel. A smaller group applying it to the scalp, often alongside microneedling, reports less shedding within a month or two and thicker-feeling hair over three to six months. On the adverse side, irritation — redness, itching, dryness — is the most frequent complaint, usually tied to starting at too high a concentration; a minority describe a 'purging' breakout phase or the so-called 'copper uglies,' where skin looks duller rather than better. Community guides consistently warn against layering GHK-Cu with vitamin C or strong acids in the same step, since the combination can break down the copper-peptide complex [1]. The cited literature adds its own cautions. Injectable or systemic GHK-Cu use is unapproved, with essentially no human pharmacokinetic basis — the closest data point is a rat study showing the free peptide clears quickly from blood. Copper accumulation with prolonged systemic use is a theoretical concern relevant mainly to people with copper-handling conditions, though no human copper-toxicity case has been tied to GHK-Cu in the published record. Human evidence stays limited to small topical trials [1][4], and much of the foundational literature traces to a single research group — reason enough to read the boldest anti-aging claims with some caution. ## Where it fits in cellular energy and metabolism GHK-Cu is this desk's edge case, and it is worth stating plainly rather than glossing over. Its documented mechanism is tissue and collagen remodeling — not energy metabolism in the sense that applies to [MOTS-c](/mots-c), [retatrutide](/retatrutide), or [tirzepatide](/tirzepatide). What earns it a place in the frame is narrower: copper is a cofactor cells depend on, and GHK-Cu's broad transcriptomic signature includes strong activation of antioxidant and DNA-repair gene programs alongside suppression of inflammatory NF-kB signaling [2] — redox and repair biology that sits adjacent to, but is not the same as, the AMPK/insulin-secretion machinery the other three compounds engage directly. Where MOTS-c is a mitochondrial fuel-status signal and tirzepatide/retatrutide are receptor agonists that change how the body handles glucose, GHK-Cu is a matrix-remodeling and gene-expression modulator whose evidence base is dermatological, not metabolic. Compare all four directly on the [comparison page](/compare). --- A data-forward digest of peptide research — effect sizes and study designs, reported as measured, never as a prescription.